Brazil does not expect to finish AstraZeneca vaccines locally until March – Fiocruz

RIO DE JANEIRO (Reuters) – Brazil’s Fiocruz biomedical institute said on Tuesday it would not be able to deliver finished doses of a coronavirus vaccine developed by AstraZeneca until March due to a delayed shipment of active ingredients from China.

Initially, Fiocruz had estimated it would be able to deliver 1 million AstraZeneca doses by mid-February.

(Reporting by Pedro Fonseca)